The Valley Desk

Clinical trial reportLeukemia researchPublished

Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Clinical trial report
Venue
Leukemia research
Published
Subject terms
Humans; Neoplasm Recurrence, Local; Aminopyridines; Triazines; Isocitrate Dehydrogenase; Prognosis; Drug Resistance, Neoplasm; Mutation; Adult; Aged; Aged, 80 and over; Middle Aged
PubMed ID
38564986
Added to directory
Source checked

Report a correction or request removal